178 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
101 | 24501149 | Hyperinsulinemia Alters Myoinositol to d-chiroinositol Ratio in the Follicular Fluid of Patients With PCOS. | 2014 Jul | 1 |
102 | 24505965 | [The role of inositol deficiency in the etiology of polycystic ovary syndrome disorders]. | 2014 Jan | 2 |
103 | 24601829 | Modulatory role of D-chiro-inositol (DCI) on LH and insulin secretion in obese PCOS patients. | 2014 Jun | 2 |
104 | 24606639 | Myo-inositol modulates insulin and luteinizing hormone secretion in normal weight patients with polycystic ovary syndrome. | 2014 May | 2 |
105 | 24614687 | Insights into the pathophysiology of catch-up compared with non-catch-up growth in children born small for gestational age: an integrated analysis of metabolic and transcriptomic data. | 2014 Aug | 1 |
106 | 24876842 | The Efficacy of Inositol and N-Acetyl Cysteine Administration (Ovaric HP) in Improving the Ovarian Function in Infertile Women with PCOS with or without Insulin Resistance. | 2014 | 1 |
107 | 24898153 | Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome. | 2014 Sep | 1 |
108 | 25010620 | Inositol: history of an effective therapy for Polycystic Ovary Syndrome. | 2014 Jul | 4 |
109 | 25042908 | The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome. | 2014 Oct | 3 |
110 | 25054962 | [Myo-inositol in the treatment of polycystic ovary syndrome]. | 2014 Jun | 3 |
111 | 25245999 | Resveratrol, inositol, vitamin D and K in the prevention of cardiovascular and osteoporotic risk: a novel approach in peri- and postmenopause. | 2014 Oct | 1 |
112 | 25373012 | [Combination inositol and glucomannan in PCOS patients]. | 2014 Dec | 2 |
113 | 23336594 | Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study. | 2013 Apr | 1 |
114 | 23412023 | [Evaluation of the myo-inositol-monacolin K association on hyperandrogenism and on the lipidic metabolism parameters in PCOS women]. | 2013 Feb | 2 |
115 | 23467955 | The Combined therapy myo-inositol plus D-Chiro-inositol, in a physiological ratio, reduces the cardiovascular risk by improving the lipid profile in PCOS patients. | 2013 Feb | 2 |
116 | 23596182 | The effect of insulin infusion on the metabolites in cerebral tissues assessed with proton magnetic resonance spectroscopy in young healthy subjects with high and low insulin sensitivity. | 2013 Sep | 3 |
117 | 23764390 | Potential role and therapeutic interests of myo-inositol in metabolic diseases. | 2013 Oct | 7 |
118 | 23981814 | Combination of inositol and alpha lipoic acid in metabolic syndrome-affected women: a randomized placebo-controlled trial. | 2013 Aug 28 | 3 |
119 | 24219712 | Myoinositol: a new marker of intrauterine growth restriction? | 2013 Nov | 2 |
120 | 22192068 | One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome. | 2012 Oct | 1 |
121 | 22587479 | CONCERN: Does ovary need D-chiro-inositol? | 2012 May 15 | 1 |
122 | 22592687 | Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. | 2012 May 16 | 1 |
123 | 22612517 | Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients. | 2012 Dec | 4 |
124 | 23232537 | [Evaluation of the treatment with D-chiro-inositol on levels of oxidative stress in PCOS patients]. | 2012 Dec | 1 |
125 | 20587749 | Deletion of Nck1 attenuates hepatic ER stress signaling and improves glucose tolerance and insulin signaling in liver of obese mice. | 2011 Mar | 2 |
126 | 20811299 | Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study. | 2011 Jan | 1 |
127 | 20814537 | Metabolomics reveals relationship between plasma inositols and birth weight: possible markers for fetal programming of type 2 diabetes. | 2011 | 2 |
128 | 21300338 | The role of inositol supplementation in patients with polycystic ovary syndrome, with insulin resistance, undergoing the low-dose gonadotropin ovulation induction regimen. | 2011 Jun 30 | 2 |
129 | 21414183 | The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. | 2011 Aug | 5 |
130 | 21514580 | The role of inositol supplementation in patients with polycystic ovary syndrome, with insulin resistance, undergoing the low-dose gonadotropin ovulation induction regimen. | 2011 Jun 30 | 1 |
131 | 21845803 | Inositol safety: clinical evidences. | 2011 Aug | 1 |
132 | 22452173 | [Myoinositol--alternative treatment of insulin resistance in adolescents]. | 2011 | 3 |
133 | 20091537 | Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. | 2010 Jan 20 | 1 |
134 | 20156067 | Uncoupling between insulin and release of a D-chiro-inositol-containing inositolphosphoglycan mediator of insulin action in obese women With polycystic ovary syndrome. | 2010 Apr | 3 |
135 | 19059532 | Hyperinsulinemia is closely related to low urinary clearance of D-chiro-inositol in men with a wide range of insulin sensitivity. | 2009 Jan | 1 |
136 | 19492925 | Increased inositol phosphoglycan P-type in the second trimester in pregnant women with type 2 and gestational diabetes mellitus. | 2009 | 2 |
137 | 19499845 | Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial. | 2009 Mar-Apr | 2 |
138 | 19551544 | Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome. | 2009 Aug | 1 |
139 | 19800728 | Contribution of myo-inositol to reproduction. | 2009 Dec | 2 |
140 | 19821299 | Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. | 2009 Oct 7 | 1 |
141 | 18335328 | Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome. | 2008 Mar | 1 |
142 | 18375940 | Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism. | 2008 Jun | 1 |
143 | 18609357 | Release of inositol phosphoglycan P-type by the human placenta following insulin stimulus: a multiple comparison between preeclampsia, intrauterine growth restriction, and gestational hypertension. | 2008 Aug | 1 |
144 | 18803944 | Insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome. | 2008 Oct | 3 |
145 | 18940392 | Relationships between urinary inositol excretions and whole-body glucose tolerance and skeletal muscle insulin receptor phosphorylation. | 2008 Nov | 3 |
146 | 17116762 | Inositol phosphoglycan P-type in preeclampsia: a novel marker? | 2007 Jan | 1 |
147 | 17537518 | Preeclampsia, insulin signalling and immunological dysfunction: a fetal, maternal or placental disorder? | 2007 Dec | 2 |
148 | 17664885 | Altered urinary release of inositol phosphoglycan A-type in women with gestational diabetes mellitus. | 2007 | 1 |
149 | 17952759 | Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction. | 2007 Dec | 2 |
150 | 16443877 | Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome. | 2006 Feb | 1 |